hl7-fhir
(5)
Ethermed
Ethermed is a Philadelphia-based health technology company that uses large language models and clinical reasoning to automate prior authorization - the paperwork-heavy approval process between healthcare providers and insurers. Its platform intercepts physician orders, gathers documentation, compares payer guidelines, fills forms and submits requests with an audit trail, cutting approval times from days to minutes. Founded in 2021 by Dan Friedman and Michal Such, the company raised an $8.5M Series A in April 2026, bringing total funding above $15M.
IgniteData
IgniteData is a healthtech company automating the transfer of clinical trial data between hospital electronic health records (EHRs) and sponsors' electronic data capture (EDC) systems. Its flagship platform, Archer, is a cloud-based, system-agnostic 'Virtual Research Assistant' that uses HL7 FHIR and SMART on FHIR APIs to move clinically validated data securely and automatically, cutting manual transcription, reducing source data verification, and helping treatments reach patients faster. Founded in the UK and now operating on both sides of the Atlantic, IgniteData works with pharmaceutical sponsors like AstraZeneca and research hospitals including UCLH, Cambridge University Hospitals, and Memorial Sloan Kettering Cancer Center.
RISA Labs
RISA Labs is a Palo Alto healthtech company building an AI operating system for oncology. Its platform, BOSS (Business Operating System as a Service), decomposes the paperwork-heavy work of cancer care - prior authorization, benefits verification, eligibility checks, denial management - into micro-tasks handled by a network of AI agents, digital twins, and reinforcement learners that plug into EHRs and payer portals. Founded in 2024 by IIT Kanpur alumni Kshitij Jaggi and Kumar Shivang, RISA aims to cut the days-long administrative delays that keep cancer patients waiting for treatment.
Zach Taft
Zach Taft is the CEO of IgniteData, a healthcare technology company whose Archer platform automates the transfer of clinical trial data straight from hospital electronic health records into pharma data-capture systems. Brought in by the founders in 2024, he has scaled the company from a handful of trial sites to a network spanning four continents and eight of the top ten U.S. cancer centers. Before IgniteData he helped drive the $1.1B acquisition of M*Modal by 3M, served as a 3M product leader, and ran digital innovation and ventures at Memorial Sloan Kettering, where he co-founded the Clinical Research Innovation Consortium. His obsession: cutting the weeks of manual data re-typing out of clinical trials so treatments reach patients faster.
Rad AI
Rad AI builds generative-AI software that drafts the most tedious parts of a radiology report - the impressions, the follow-ups, the boilerplate - so radiologists can spend more time on the images and less on the keyboard. Founded in 2018 by a radiologist (Jeff Chang) and a serial founder (Doktor Gurson), the company now works with roughly nine of the ten largest radiology groups in the U.S. and touches close to half of the country's medical imaging.